Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Augmented Reality Start-Up Raises $4m Internally To Fund US Launch

Executive Summary

Augmedics' employees formed a limited liability company and raised $4m from employees to finance the launch of the company's augmented reality surgical guidance system.

You may also be interested in...



Augmedics Raises $36M To Support Stereotactic Surgical Navigation

The company is marketing the xvision spine system, the only FDA-approved augmented reality surgical image guidance system.

Start-Up Spotlight: Augmedics, Bringing X-Ray Vision To The Surgical Table

Israeli start-up Augmedics is developing an augmented reality vision system designed to give surgeons "X-ray vision." The company's ViZOR system uses see-through AR optics to project a 3D image of a patient's spine onto a surgeon's retina, in real-time.

Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio

Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142410

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel